Adlai Nortye Ltd. - ADR

XNAS:ANL  
1.01
-0.19 (-15.83%)
6:38:31 PM EDT: $1.01 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Adlai Nortye Ltd. - ADR Stock, XNAS:ANL

Building 6 & 8, 1008 Xiangwang Street, Hangzhou, Zhejiang 311100
United States of America
Phone: +86.571.289.8385
Number of Employees:
http://www.adlainortye.com

Description

Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.